Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh |
| Country | Germany |
| Start Date | Sep 01, 2023 |
| End Date | Aug 31, 2027 |
| Duration | 1,460 days |
| Number of Grantees | 27 |
| Roles | Participant; Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101120466 |
Optimising biological activity and physico-chemical properties, while minimising their toxicity, are objectives when developing new compounds in chemical industries. Advanced machine learning (AI) methods are indispensable to this process.
They are also increasingly used in environmental chemistry to identify compounds damaging to the environment and humans.
Traditional machine learning (ML) methods provide reliable predictions though only for compounds similar to the training set, thus defining their applicability domain (AD).
Emerging representation learning approaches can efficiently approximate the physical interactions of molecules with an accuracy comparable to physics-based methods in only fractions of time.
Models based on these representations should have much larger AD due to pre-training on large chemical sets of theoretical values.
Here we will develop and benchmark representation learning approaches, addressing their accuracy and ADs, using public and in-house data for endpoints ranging from chemical reactions to toxicity.
While explainable AI (XAI) methods are actively developing in the ML community, there is a gap with their use in chemistry, i.e. there is a need to translate their results to the end users, chemists and regulatory bodies.
Since the research program is tightly coupled with the target users - large companies, regulatory agencies and SMEs - it provides a clear path for technology transfer from academia to industry.
AiChemist will provide structured training to its fellows through a combination of online courses and schools, strengthening European innovation capacity in the education of specialists in AI methods. The fellows will receive comprehensive training in transferable skills.
The complementary expertise and strong commitment of the partners make this ambitious innovative research program realistic via the proper allocation of individual tasks and resources, as described below.
Pfizer Pharma Gmbh; Universiteit Leiden; Ascenion Gmbh; Altamira Llc; Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh; Istituto Di Ricerche Farmacologiche Mario Negri; Technische Universitaet Muenchen; Astrazeneca Ab; Molecular Networks Gmbh Computerchemie; Kobenhavns Universitet; Universite de Strasbourg; Ecole Polytechnique Federale de Lausanne; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Ecole Normale Superieure; European Chemicals Agency; Universita Della Svizzera Italiana; National Institutes of Health; Universitat de Barcelona; Syngenta Crop Protection Ag; Bayer Aktiengesellschaft; Sanofi-Aventis Recherche & Developpement; Cehtra; Chelonia Sa; Technische Universiteit Eindhoven; Korea Research Institute of Chemical Technology; Fundacio Centre de Regulacio Genomica; U.S. Food & Drug Administration
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant